Therapeutic precision gene editing of cholesterol pathways as a gene therapy strategy for cardiovascular disease, explores a transformative alternative: a single-dose, precision-based gene therapy capable of achieving long-lasting cholesterol reduction.
https://t.co/B5QGvGVftr
My dear colleagues,
We are delighted to share our newest article on genome editing and hope you find the content valuable. We encourage you to review the findings and consider their potential impact on the future of medical genetics. https://t.co/8uexAK6ivG
This year's Precision Medicine World Conference (@PMWCintl) is right around the corner!
For those who can join, @davidrliu's presentation will be part of the "Cell & Gene Therapies" Track on 02/06.
Full program lineup: https://t.co/Umj70tEdvz
The European Commission gave conditional approval to Hemgenix, an infusion gene therapy for adults with hemophilia B and no inhibitors. https://t.co/LDZogdHkJt